CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $391,200
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$391,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-16 | Kaplan Myron Director | Purchase | +6,000 | $8.06 | $48K | 104,734 |
| 2019-08-16 | Dillione Janet Director | Purchase | +6,147 | $8.19 | $50K | 53,473 |
| 2019-08-14 | Dillione Janet Director | Grant or award · Phantom Stock | +945 | 945 | ||
| 2019-07-12 | DUNTON ALAN W Director | Grant or award | +1,250 | 1,250 | ||
| 2019-07-12 | DUNTON ALAN W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +7,500 | 7,500 | ||
| 2019-05-15 | Dillione Janet Director | Purchase | +11,144 | $6.74 | $75K | 47,326 |
| 2019-05-15 | Dillione Janet Director | Grant or award · Phantom Stock | +1,126 | 226 | ||
| 2019-05-01 | Mounts Phoebe General Counsel | Grant or award · Stock Option (Right to Buy Common Stock) | +70,000 | 70,000 | ||
| 2019-03-29 | Cook Robert W. Chief Financial Officer | Purchase | +100 | $9.35 | $935 | 25,517 |
| 2019-03-26 | Baluch Khoso Chief Executive Officer | Purchase | +2,500 | $7.55 | $19K | 52,575 |
| 2019-03-26 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Purchase | +5,000 | $7.73 | $39K | 69,378 |
| 2019-03-25 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Purchase | +15,000 | $1.69 | $25K | 321,890 |
| 2019-03-22 | Kaplan Myron Director | Purchase | +20,000 | $1.65 | $33K | 493,666 |
| 2019-03-18 | Dillione Janet Director | Purchase | +42,000 | $1.67 | $70K | 180,909 |
| 2019-03-01 | DUNTON ALAN W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2019-03-01 | DUNTON ALAN W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +100,000 | 100,000 | ||
| 2019-02-14 | Dillione Janet Director | Grant or award · Phantom Stock | +4,213 | $1.78 | $7K | 4,213 |
| 2019-01-10 | Masson Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +120,000 | 120,000 | ||
| 2019-01-10 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +400,000 | 400,000 | ||
| 2019-01-10 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Grant or award · Stock Option (Right to Buy Common Stock) | +45,000 | 45,000 |
Page 15 of 16 · 301 trades